Ginger and Parkinson's Disease: Neuroprotection and Dopamine

Parkinson's disease, the second most common neurodegenerative disease globally, involves the progressive destruction of dopaminergic neurons in the substantia nigra. Ginger, thanks to its neuroprotective compounds, is the subject of increasing scientific research.

Neuroprotective mechanisms of ginger

6-shogaol, a bioactive compound in ginger, exhibits several documented neuroprotective properties:

• Anti-neuroinflammation: inhibits microglial activation (immune cells in the brain) that destroy dopaminergic neurons
• Cerebral antioxidant: crosses the blood-brain barrier, reduces cortisol-naturel">ginger oxidative stress in the substantia nigra
• Mitochondrial protection: preserves the function of neuronal mitochondria (a key target in Parkinson's)

Promising preclinical studies

Studies on animal models (Neurochemical Research, 2019; Phytomedicine, 2021) show that ginger extract:

• Reduces dopaminergic neuron loss by 40-60% in MPTP models
• Improves behavioral markers (motor skills, coordination)
• Reduces α-synuclein accumulation (a central protein in Parkinson's pathology)

Note: These are preclinical (animal) studies. Human clinical trials are ongoing, but direct evidence in humans remains limited.

Ginger as a complement to conventional treatments

Ginger does not replace L-DOPA or dopaminergic agonists. It can be considered as complementary support, particularly for:

• Reducing systemic inflammation (a known aggravating factor)
• Improving bloating-reflux-nausees">ginger and digestion (frequently disrupted in Parkinson's)
• Supporting general neuroprotection

INTI Drink: optimal bioavailability

INTI's concentrated liquid form maximizes the absorption of ginger's bioactive compounds. No added sugar (1.19g/100ml vs ~34g for INTI vs GIMBER comparison) — important because chronic hyperglycemia exacerbates neuroinflammation.

Consult a neurologist before making any changes to Parkinson's treatment.